CLINICAL_TRIALS
trial_result
· 2024-03-26
Clinical Trial Update: Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2 study evaluating subcutaneous belimumab in pediatric patients with systemic lupus erythematosus. The study results were posted on 2024-03-26.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-26